Dermal filler is a naturally occurring sugar known as Hyaluronic Acid (HA). HA is found throughout the body in tissues (such as skin), cartilage and bone. When we are young, the body produces an abundance of HA and this makes our skin and tissue structures (such as cheeks) look plump, firm and our skin vibrant. As we age, our body produces less HA and this is at the core of the ageing process. A reduction in HA makes our skin appear dehydrated, increases lines and wrinkles and contributes to other tell-tale signs of ageing.
Dermal filler, such as Restylane®, Juvederm® or Emervel®, is used to replace lost HA. Small amounts are injected directly into areas where HA loss has contributed to the appearance of ageing, to rejuvenate the appearance. Dermal filler can be used to treat the following concerns (and more):
- Lips – to provide hydration, subtle enhancement to the pout, fill smokers lines
- Cheeks – to provide volume and structure, enhance cheekbones and improve the eye region
- Around the nose and mouth – to reduce folds caused by ageing and improve structure
- Jawline – to provide structure and enhance the face
- Temples – to fill hollowing temples and subtly lift the face
A thorough consultation is very important to identify if dermal filler is appropriate for you, which product should be used and to identify a realistic outcome for treatment. Please contact us on (09) 360 4078 to book a consultation with Dr Paul or one of his Nurses to find out if dermal filler is appropriate for your concerns.
The JUVÉDERM® range of injectable gels are medical devices for use in adults. JUVÉDERM® ULTRA XC and JUVÉDERM® ULTRA PLUS XC contain 24mg/mL cross-linked hyaluronic acid with lidocaine 3mg/mL. JUVÉDERM® ULTRA XC is for filling medium-sized depressions of the skin as well as for lip definition. JUVÉDERM® ULTRA PLUS XC is for filling mid and/or deep depressions of the skin as well as for lip definition and enhancement. JUVÉDERM® VOLUMA® with lidocaine contains 20mg/mL cross-linked hyaluronic acid with lidocaine 3mg/mL and is intended to restore volume of the face. JUVÉDERM® VOLIFT® with lidocaine contains 17.5mg/mL cross-linked hyaluronic acid with lidocaine 3mg/mL and is intended for the treatment of deep skin depressions, for face contouring or volume restoration of the face. JUVÉDERM® VOLBELLA® with lidocaine contains 15mg/mL cross-linked hyaluronic acid with lidocaine 3mg/mL and is intended for the treatment of any fine lines and medium-sized skin depressions or the enhancement and pouting of lips. JUVEDERM® VOLITE™ contains 12 mg/mL cross-linked hyaluronic acid with lidocaine 3mg/mL and is intended to be used for the treatment, by filling, of superficial cutaneous depressions such as fine lines and for additional improvement of skin quality attributes such as hydration and elasticity, via intradermal injection. All JUVÉDERM® products should be administered only by a trained healthcare professional. JUVÉDERM® ULTRA XC, JUVÉDERM® ULTRA PLUS XC and JUVEDERM® VOLITE™ should not be injected into the eyelids. JUVÉDERM® VOLUMA® with lidocaine should not be injected in the periorbital area (eyelids, under-eye area, crow’s feet), glabellar region or in the lips. JUVÉDERM® VOLBELLA® with lidocaine should not be injected into the eyelids. Application in the bags under the eyes is reserved for trained specialists. JUVÉDERM® VOLIFT® with lidocaine should not be injected in the periorbital area (eyelids, under-eye area, crow’s feet) and glabellar region. You should not receive treatment with any JUVÉDERM® product if you are below 18 years of age, have untreated epilepsy, history of hypertrophic scars or porphyria, or if you are pregnant or breastfeeding, hypersensitivity to ingredients including hyaluronic acid, lidocaine or amide-type local anaesthetics, any areas of cutaneous inflammation and/or infections, or if you have just had laser treatment, deep chemical peel or dermabrasion. Precautions: Caution is required if you have received treatment with another dermal filler; if you have a history of or are currently suffering an auto-immune disease, severe multiple allergies, anaphylactic shock, streptococcal disease, symptoms of cardiac conduction disorders; or if you are taking certain medications including anti-coagulants or certain drugs that reduce/inhibit hepatic metabolism. Avoid makeup for 12 hours after injection and prolonged exposure to sunlight/UV light/extreme temperatures for 2 weeks. Adverse effects reported after treatment with JUVÉDERM® range of fillers have included immediate or delayed injection site inflammatory reactions (redness/swelling/ itching/pain on pressure) persisting a week post treatment, haematomas, induration or nodules, discolouration, weak filling effect, risk of infection, abscess formation, granuloma, necrosis or hypersensitivity. Please ask your doctor or request for the Directions For Use for complete list of precautions and adverse effects per respective filler. JUVÉDERM® injectable gels are not funded on the New Zealand Pharmaceutical Scheme. You will need to pay for this treatment. Normal Doctors visit fees apply. Speak to your specialist about your own situation and about the benefits/ risks of this procedure in appearance medicine. If you have any side effects or concerns speak to your doctor. Note: JUVÉDERM® treatment may last up to 1–2 years and further courses of treatment may be necessary. (September 2018).
™®Trademark(s) and registered trademark(s) of Allergan, Inc. Allergan Australia Pty Ltd. 810 Pacific Highway, Gordon NSW 2072. ABN 85 000 612 831. Allergan New Zealand Limited, Auckland. © 2018 Allergan. All rights reserved. Date of preparation: October 2018 ANZ/0104/2017.
Restylane® is a natural cosmetic dermal filler that restores volume and fullness to the skin to smooth facial wrinkles and folds, enhance facial shape or to create fuller lips. Restylane® is available through prescription only from a medical professional, and is
delivered by injection into or below the skin. It is not to be injected into blood vessels as this may lead to a lack of blood supply to the skin and ulceration and scarring. Restylane® contains hyaluronic acid, naturally found in the human body and is thought
to help increase moisture in the skin. Treatment benefits are instant, do not affect facial expression and results usually last 6-12 months. Ongoing treatments are needed to maintain best results. After a Restylane® treatment you may expect some degree of
redness, swelling, pain or tenderness, itching and/or bruising which generally only lasts a few days. Inflammatory reactions may last up to two weeks in rare cases. Adverse effects from treatment are extremely rare and may include allergy, infection, granuloma
formation, persistent discoloration at the injection site, and/or ulceration of the skin. Exposure to sunlight should be avoided during the initial post treatment phase. Restylane® should not be used in or near sites where there are active skin disease,
inflammation or infection, or where a permanent implant has been placed. Restylane® is not recommended for people taking blood thinning medicines or Roaccutane for acne, and has not been tested in pregnant or breast-feeding women. Restylane® is
an unfunded Prescription medicine, and there will be a charge for the medicine and consultation. Ask you specialist if Restylane is right for you. Contains: Hyaluronic acid 20mg/ml phosphate buffered saline, pH 7 q.s. Q-Med Ltd, Auckland. Distributed by Healthcare Logistics, Auckland.